Menu

Recovering Lost Memories

Researchers use optogenetics to induce recall in an Alzheimer’s mouse model, suggesting the disease may not destroy memories permanently.

Mar 21, 2016
Jef Akst

FLICKR, DAY DONALDSONMice genetically engineered to exhibit Alzheimer’s disease-like symptoms quickly forget a learned association between an environment and a painful stimulus, such as a foot shock. But using light to stimulate cells of the hippocampus, where short-term memories are encoded, MIT’s Susumu Tonegawa and colleagues could seemingly reinstate the environment-triggered fear in those forgetful mice, according to a study published last week (March 16) in Nature.

“Even if a memory seems to be gone, it is still there,” Tonegawa told The Washington Post. “It’s a matter of how to retrieve it.” The researchers speculate that the neural stimulation prompted the hippocampal neurons to regrow dendritic spines and reestablish connections with other neurons.

The findings have “shattered a 20-year paradigm of how we’re thinking about the disease,” Harvard neurology professor Rudy Tanzi, who was not involved in the research, told the Boston Herald.

While the optogenetic technique used in the study cannot be immediately translated to humans, deep-brain stimulation may one day serve as a viable alternative, Columbia University neurobiologist Christine Denny told The Washington Post.

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.